A Comprehensive Review on the 3D Printing Technology In Drug Delivery

Three-dimensional (3D) printing, which is also called additive manufacturing, is a newer technology that has drawn a lot of interest in pharmaceutical sciences, since it could make drug delivery better and support personalized medicine. This review gives an overview of the basic principles of 3D printing, along with its historical development, classification, and main techniques, such as fused deposition modeling (FDM), direct powder extrusion (DPE), stereolithography (SLA), selective laser sintering (SLS), binder jetting, and inkjet printing. It also looks at the various materials used in pharmaceutical 3D printing, including polymers, metals, ceramics, and smart materials, and at how they help create customized dosage forms and advanced drug delivery systems. The review points out the main benefits of this technology, such as personalized dosing, accurate drug delivery, controlled drug-release profiles, putting several drugs into one dosage form, less material waste, and the chance to manufacture on demand. It goes on to explore opportunities in personalized medicine, fast-dissolving tablets, drug-loaded implants, and formulations made for individual patients. Still, a number of challenges remain, such as nozzle blockage, material incompatibility, drug degradation during processing, printing defects, high equipment costs, slow production rates, and regulatory difficulties. For this reason, risk assessment and quality control are needed to check drug content uniformity, weight variation, mechanical strength, dissolution behaviour, and product stability.In addition, this review looks at future prospects and emerging trends in pharmaceutical 3D printing, such as artificial intelligence (AI), machine learning, smart materials, 4D printing, 3D-printed polypills, advanced drug-release systems, automated quality monitoring, and industrial manufacturing. It also covers clinical applications, the current status of 3D-printed medicines, regulatory requirements, and research gaps that still need to be addressed. Even though its potential is promising, more studies are needed on safety, effectiveness, long-term stability, process validation, and large-scale manufacturing. All in all, 3D printing is a promising way to move personalized medicine forward and to develop flexible, patient-centred drug delivery systems.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-21
DOI
https://doi.org/10.5281/zenodo.24414193
Primary Topic
Additive Manufacturing and 3D Printing Technologies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A Comprehensive Review on the 3D Printing Technology In Drug Delivery

Shriram Bairagi, Pooja Rothe, Amol Pardhi
Zenodo (CERN European Organization for Nuclear Research)
Additive Manufacturing and 3D Printing Technologies
article

A Comprehensive Review on the 3D Printing Technology In Drug Delivery

Shriram Bairagi, Pooja Rothe, Amol Pardhi
article en

Abstract

Three-dimensional (3D) printing, which is also called additive manufacturing, is a newer technology that has drawn a lot of interest in pharmaceutical sciences, since it could make drug delivery better and support personalized medicine. This review gives an overview of the basic principles of 3D printing, along with its historical development, classification, and main techniques, such as fused deposition modeling (FDM), direct powder extrusion (DPE), stereolithography (SLA), selective laser sintering (SLS), binder jetting, and inkjet printing. It also looks at the various materials used in pharmaceutical 3D printing, including polymers, metals, ceramics, and smart materials, and at how they help create customized dosage forms and advanced drug delivery systems. The review points out the main benefits of this technology, such as personalized dosing, accurate drug delivery, controlled drug-release profiles, putting several drugs into one dosage form, less material waste, and the chance to manufacture on demand. It goes on to explore opportunities in personalized medicine, fast-dissolving tablets, drug-loaded implants, and formulations made for individual patients. Still, a number of challenges remain, such as nozzle blockage, material incompatibility, drug degradation during processing, printing defects, high equipment costs, slow production rates, and regulatory difficulties. For this reason, risk assessment and quality control are needed to check drug content uniformity, weight variation, mechanical strength, dissolution behaviour, and product stability.In addition, this review looks at future prospects and emerging trends in pharmaceutical 3D printing, such as artificial intelligence (AI), machine learning, smart materials, 4D printing, 3D-printed polypills, advanced drug-release systems, automated quality monitoring, and industrial manufacturing. It also covers clinical applications, the current status of 3D-printed medicines, regulatory requirements, and research gaps that still need to be addressed. Even though its potential is promising, more studies are needed on safety, effectiveness, long-term stability, process validation, and large-scale manufacturing. All in all, 3D printing is a promising way to move personalized medicine forward and to develop flexible, patient-centred drug delivery systems.

Zenodo (CERN European Organization for Nuclear Research)
Additive Manufacturing and 3D Printing Technologies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon